Summarized by Masters of Longevity from Nature - Main.
Report on how the surge of consumer wearable health data is challenging clinical workflows and prompting trials and protocols to integrate device outputs into care.
Key Takeaways
- REACT-AF randomizes atrial fibrillation patients to usual anticoagulation or smartwatch-guided temporary medication restarts.
- Consumer smartwatches can detect multiple arrhythmias but carry substantial false-positive risk due to inaccurate readings.
- A controlled trial found smartwatches correctly identified 77% of falls with a 1.7% false-positive rate.
